The most common STIs are chlamydia, gonorrhea, trichomoniasis, hepatitis, genital herpes, HIV, HPV, mycoplasma and syphilis.
Untreated STIs can lead to severe health problems in men and women, such as reproductive health problems, pelvic inflammatory disease, ectopic pregnancy, preterm birth, and infertility.
Most people who have chlamydia, gonorrhea or trichomonas do not have symptoms. Rapid diagnosis and screening can improve treatment, reduce complications and reduce the transmission of STIs.
Molecular PCR is the golden standard for diagnosis but is usually performed in the central lab with up to 5 days turnaround time. Patients often get empirically treated before the lab results come in or patients may be lost to follow up. This can cause mistreatment, discomfort for the patients, insecurities, and further spreading of STIs, without realizing.
Unique silicon chip technology allowing for ultra-fast PCR
Built-in controls ensure the highest quality result
Closed reaction chamber limits risk of contamination and cross-infection
Sends reports directly to laboratory/POC information systems, or network printer
“miDiagnostics has the potential to disrupt and transform the industry by making diagnostic information available to clinician and patient alike.”
“Its easy-to-use and cost-efficient test will revolutionize point-of-care testing by directly engaging with patients and enabling speedy intervention.”
“Proud to be leading a top team and together with our numerous partners to make a significant contribution to healthcare in general.”
“As a Non-Executive Director on miDiagnostics’ Board, I have been privileged to witness its continued development. I am very proud to see many years of hard work coming to fruition and providing value, facilitating the return to a normal way of life, with potential to move high quality testing closer to the patient.”
“This technology could aid the management of outbreaks in challenging settings, such as nursing homes and home care environments, allowing healthcare professionals to adjust their management decisions at the point of care. ”